Literature DB >> 22478826

Oncology Biomarker Diagnostics: Where We Are, Where We Need To Be: Identifying cancer biomarkers that are clinically useful is difficult. So is obtaining funding to get biomarker diagnostics to market.

Sarah Collins.   

Abstract

Entities:  

Year:  2010        PMID： 22478826      PMCID： PMC2957736     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


× No keyword cloud information.
  2 in total

1.  American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors.

Authors:  Timothy D Gilligan; Jerome Seidenfeld; Ethan M Basch; Lawrence H Einhorn; Timothy Fancher; David C Smith; Andrew J Stephenson; David J Vaughn; Roxanne Cosby; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2010-06-07       Impact factor: 44.544

2.  Temporary Assistance for Needy Families (TANF) carry-over funds. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2010-04-06
  2 in total
  1 in total

Review 1.  MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.

Authors:  Christiane Matuszcak; Joerg Haier; Richard Hummel; Kirsten Lindner
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.